498 related articles for article (PubMed ID: 23608641)
1. Oral delivery of proteins by biodegradable nanoparticles.
Bakhru SH; Furtado S; Morello AP; Mathiowitz E
Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanoparticles with novel non-peptidic ligands for oral delivery.
des Rieux A; Pourcelle V; Cani PD; Marchand-Brynaert J; Préat V
Adv Drug Deliv Rev; 2013 Jun; 65(6):833-44. PubMed ID: 23454185
[TBL] [Abstract][Full Text] [Related]
4. Oral drug delivery systems using chemical conjugates or physical complexes.
Al-Hilal TA; Alam F; Byun Y
Adv Drug Deliv Rev; 2013 Jun; 65(6):845-64. PubMed ID: 23220326
[TBL] [Abstract][Full Text] [Related]
5. Engineering strategies to enhance nanoparticle-mediated oral delivery.
Yamanaka YJ; Leong KW
J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
10. Challenges and advances in nanoparticle-based oral insulin delivery.
Ramesan RM; Sharma CP
Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yun Y; Cho YW; Park K
Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
[TBL] [Abstract][Full Text] [Related]
12. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
14. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
Shahbazi MA; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
16. Nanocarrier systems for oral drug delivery: do we really need them?
Bernkop-Schnürch A
Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
[TBL] [Abstract][Full Text] [Related]
17. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.
Roger E; Lagarce F; Garcion E; Benoit JP
Nanomedicine (Lond); 2010 Feb; 5(2):287-306. PubMed ID: 20148639
[TBL] [Abstract][Full Text] [Related]
19. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
Kriegel C; Attarwala H; Amiji M
Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
[TBL] [Abstract][Full Text] [Related]
20. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
